Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:458-464
Published online before print January 22, 2009, doi: 10.1161/ATVBAHA.109.183772
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/4/458    most recent
ATVBAHA.109.183772v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koga, J.-i.
Right arrow Articles by Sunagawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koga, J.-i.
Right arrow Articles by Sunagawa, K.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:458.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice

Jun-ichiro Koga; Tetsuya Matoba; Kensuke Egashira; Mitsuki Kubo; Miho Miyagawa; Eiko Iwata; Katsuo Sueishi; Masabumi Shibuya; Kenji Sunagawa

From the Department of Cardiovascular Medicine (J.K., T.M., K.E., M.K., M.M., E.I., K. Sunagawa) and the Division of Pathophysiological and Experimental Pathology (K. Sueishi), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and the Department of Molecular Oncology (M.S.), Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, Tokyo, Japan.

Correspondence to Kensuke Egashira, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail egashira{at}cardiol.med.kyushu-u.ac.jp

Objective— We have demonstrated that vascular endothelial growth factor (VEGF) expression is upregulated in injured vascular wall, and blockade of VEGF inhibited monocyte infiltration and neointima formation in several animal models. In the present study, we aimed to clarify relative role of two VEGF receptors, flt-1 versus flk-1/KDR, in neointima formation after injury using flt-1 tyrosine kinase-deficient (Flt-1 TK–/–) mice and soluble Flt-1(sFlt-1) gene transfer.

Methods and Results— Neointima formation was comparable between wild-type and Flt-1 TK–/– mice 28 days after intraluminal wire injury in femoral arteries. By contrast, neointima formation was significantly suppressed by sFlt-1 gene transfer into Flt-1 TK–/– mice that blocks VEGF action on flk-1 (intima/media ratio: 2.8±0.4 versus 1.4±0.4, P<0.05). The inhibition of neointima formation was preceded by significant reduction of monocyte chemoattractant protein (MCP-1) expression in vascular smooth muscle cells (VSMCs) and monocyte infiltration 7 days after injury. Gene transfer of sFlt-1 or treatment of flk-1–specific antibody significantly inhibited VEGF-induced MCP-1 expression determined by RT-PCR in cultured aortic tissue and VSMCs. MCP-1–induced chemotaxis was equivalent between wild-type and Flt-1 TK–/– mice.

Conclusions— These results suggest that endogenous VEGF accelerates neointima formation through flk-1 by regulating MCP-1 expression in VSMCs and macrophage-mediated inflammation in injured vascular wall in murine model of wire injury.


Key Words: restenosis • inflammation • smooth muscle cells • angiogenesis


Related Article:

VEGF and Restenosis: The Rest of the Story
Michael Simons
Arterioscler Thromb Vasc Biol 2009 29: 439-440. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Simons
VEGF and Restenosis: The Rest of the Story
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 439 - 440.
[Full Text] [PDF]